Where The Rx Spot fits a combined program
The Rx Spot's multi-pharmacy model is the right category for combined programs because a GLP-1 and a set of peptides often do not come from the same 503A pharmacy. Consolidating both protocols under one dashboard, instead of separate pharmacy portals, is the headline benefit when a single patient's program spans compounders.
What to confirm is how a single patient's multi-protocol order is handled. The Rx Spot does not publish detail on whether a GLP-1 from one compounder and peptides from another stay in one cart and one checkout, or whether they fragment into separate orders. And because The Rx Spot is quote-driven, per-item cost across both protocols is not visible until a sales conversation — the number you need to price a combined program.